GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » EV-to-FCF

Daito Pharmaceutical Co (TSE:4577) EV-to-FCF : (As of Mar. 27, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Daito Pharmaceutical Co's Enterprise Value is 円41,645 Mil. Daito Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Nov. 2024 was 円0 Mil. Therefore, Daito Pharmaceutical Co's EV-to-FCF for today is .

The historical rank and industry rank for Daito Pharmaceutical Co's EV-to-FCF or its related term are showing as below:

TSE:4577' s EV-to-FCF Range Over the Past 10 Years
Min: -103.94   Med: 28.37   Max: 29.56
Current: -37.62

During the past 13 years, the highest EV-to-FCF of Daito Pharmaceutical Co was 29.56. The lowest was -103.94. And the median was 28.37.

TSE:4577's EV-to-FCF is ranked worse than
100% of 549 companies
in the Drug Manufacturers industry
Industry Median: 23.39 vs TSE:4577: -37.62

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-27), Daito Pharmaceutical Co's stock price is 円2216.00. Daito Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2024 was 円171.170. Therefore, Daito Pharmaceutical Co's PE Ratio (TTM) for today is 12.95.


Daito Pharmaceutical Co EV-to-FCF Historical Data

The historical data trend for Daito Pharmaceutical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co EV-to-FCF Chart

Daito Pharmaceutical Co Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.87 -38.82 -101.45 -24.82 -36.77

Daito Pharmaceutical Co Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -36.77 - -

Competitive Comparison of Daito Pharmaceutical Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Daito Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daito Pharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daito Pharmaceutical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Daito Pharmaceutical Co's EV-to-FCF falls into.


';

Daito Pharmaceutical Co EV-to-FCF Calculation

Daito Pharmaceutical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=41645.238/0
=

Daito Pharmaceutical Co's current Enterprise Value is 円41,645 Mil.
Daito Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daito Pharmaceutical Co  (TSE:4577) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Daito Pharmaceutical Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2216.00/171.170
=12.95

Daito Pharmaceutical Co's share price for today is 円2216.00.
Daito Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円171.170.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Daito Pharmaceutical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Daito Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co Headlines

No Headlines